Perspectives from the recombinant protein production industry

Thursday March 9
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
15:50

Perspectives from the recombinant protein production industry

Trond Erik Vee Aune, Founder/CEO
Vectron Biosolutions, Norway

Vectron Biosolutions was founded in 2008 based on the expression vector technology developed in Professor Svein Valla's research group at NTNU in Trondheim, Norway. The technology can be used for higher recombinant protein manufacturing yields and the possibility of reduced protein aggregation. It is suitable for maximized production of various proteins including therapeutics and industrial enzymes, as well as controlled production for metabolic engineering applications. The goal of Vectron is to change how life science industries manufacture their recombinant proteins, in particular by reducing the associated cost-of-goods.

This lecture will draw some conclusions about being a biotech enterpreneur in this specific field, and in Norway in general, and describe how the recombinant protein industries are evolving in terms of their expression technology needs with particular emphasis on the arrival of novel manufacturing hosts.